Elizabeth Zanone
Dermatology · Darien, ILNPI 1982172599
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,428 of the $13,707 with a category attached, or 68.8%. 29 manufacturers reported payments, led by Verrica Pharmaceuticals Inc. at 34.1% of the total. 2025 is the largest year on record at $6,496, 4.7 times the $1,394 reported in 2021.
Across 402 payments — averaging $34.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Verrica Pharmaceuticals Inc.$5K
- AbbVie$2K
- Journey Medical Corporation$2K
- Galderma Laboratories, L.p.$873
- E.r. Squibb & Sons, L.L.C.$707
- VYNE Pharmaceuticals Inc.$554
- plus $4K from 23 others
What the payments were for
- Consulting fees$5004%
- Speaking & faculty fees$3,50026%
- Travel & lodging$1111%
- Food & beverage$9,42869%
- Education$1691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Verrica Pharmaceuticals Inc. | 43 | $4,676 |
| AbbVie(2 entities) | 66 | $1,762 |
| Journey Medical Corporation | 27 | $1,617 |
| Galderma Laboratories, L.p. | 55 | $873 |
| E.r. Squibb & Sons, L.L.C. | 43 | $707 |
| VYNE Pharmaceuticals Inc. | 9 | $554 |
| Lilly USA, LLC | 19 | $519 |
| Novartis | 29 | $514 |
| Johnson & Johnson | 21 | $500 |
| Sun Pharmaceutical Industries Inc. | 13 | $332 |
| Incyte Corporation | 9 | $240 |
| Mayne Pharma Commercial LLC | 18 | $229 |
| UCB, Inc. | 6 | $216 |
| Arcutis Biotherapeutics, Inc. | 17 | $184 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $142 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Dermavant Sciences, Inc. | 2 | $104 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
| Pfizer | 4 | $71 |
| Amgen | 3 | $53 |
| Boston Scientific | 1 | $48 |
| Cipher Pharmaceuticals US LLC | 1 | $33 |
| Merz North America, Inc. | 1 | $31 |
| Dermira, Inc. | 1 | $19 |
| Almirall LLC | 1 | $14 |
| Botanix SB Inc | 1 | $14 |
| Organon | 2 | $14 |
| EPI Health, LLC | 1 | $14 |
| Biofrontera Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,707 in reported general payments places this provider in the 85th percentile of 606 dermatology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $75,829 |
| Dupixent PenDupilumab | 14 | $52,388 |
| Tacrolimus | 21 | $3,856 |
| Clobetasol Propionate | 104 | $2,820 |
| Ketoconazole | 101 | $1,290 |
| Betamethasone Valerate | 34 | $932 |
| Triamcinolone Acetonide | 86 | $926 |
| Mometasone Furoate | 65 | $790 |
| Gentamicin Sulfate | 16 | $691 |
| Doxycycline Hyclate | 22 | $261 |
| Mupirocin | 22 | $149 |
| Minoxidil | 11 | $143 |
| Terbinafine Hcl | 12 | $103 |
| Prednisone | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Darien
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
- Emily RubensteinLincolnshire$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.